Avidity Biosciences, Inc. (RNAM)
Feb 27, 2026 - RNAM was delisted (reason: acquired by NVS)
71.36
0.00 (0.00%)
Inactive · Last trade price on Feb 26, 2026
Avidity Biosciences Employees
Avidity Biosciences had 511 employees as of December 31, 2025. The number of employees increased by 120 or 30.69% compared to the previous year.
Employees
511
Change (1Y)
120
Growth (1Y)
30.69%
Revenue / Employee
$36,703
Profits / Employee
-$1,339,787
Market Cap
n/a
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 511 | 120 | 30.69% |
| Dec 31, 2024 | 391 | 138 | 54.55% |
| Dec 31, 2023 | 253 | 67 | 36.02% |
| Dec 31, 2022 | 186 | 61 | 48.80% |
| Dec 31, 2021 | 125 | 54 | 76.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
RNAM News
- 19 days ago - Atrium Therapeutics Launches with Approximately $270 Million to Advance Novel RNA Medicines for Rare Genetic Cardiomyopathies - PRNewsWire
- 20 days ago - Avidity Biosciences Announces Multiple Upcoming Presentations at 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference - PRNewsWire
- 23 days ago - Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders - PRNewsWire
- 4 weeks ago - The New England Journal of Medicine Publishes Results from Phase 1/2 MARINA® Trial of Delpacibart Etedesiran (del-desiran) for Treatment of Myotonic Dystrophy Type 1 - PRNewsWire
- 6 weeks ago - Avidity Biosciences Announces Expected Record Date for Spin-Off - PRNewsWire
- 6 weeks ago - Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance - Seeking Alpha
- 7 weeks ago - Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development - Accesswire
- 2 months ago - Pharma sector doubles down on AI amid hopes of slashing costs, timelines - Reuters